Table 3.
Changes of stress related serum factors during 6 months of treatment (n=45 each group).
| Groups | NO (umol/L) | SOD (u/ml) | GSH-PX (pmol/ml) | |||
|---|---|---|---|---|---|---|
| Start | 6 months | Start | 6 months | Start | 6 months | |
| Treatment | 56.42 ± 2.31 | 27.39 ± 2.14 | 73.45 ± 4.63 | 127.59 ± 7.52 | 32.81 ± 3.51 | 72.43 ± 3.46 |
| Control | 57.42 ± 3.28 | 48.73 ± 2.89 | 74.48 ± 3.97 | 56.42 ± 2.92 | 34.05 ± 2.8 | 42.07 ± 2.45 |
| P value | 0.15 | 0.00 | 0.91 | 0.00 | 0.23 | 0.00 |
| Groups | MDA (nmol/L) | TAOC (u/ml) | ||||
| Start | 6 months | Start | 6 months | |||
| Treatment | 11.25 ± 0.32 | 4.36 ± 0.47 | 0.24 ± 0.09 | 0.34 ± 0.04 | ||
| Control | 10.98 ± 0.41 | 12.37 ± 0.25 | 0.25 ± 0.09 | 0.23 ± 0.12 | ||
| P value | 0.004 | 0.00 | 0.95 | 0.00 | ||